Related Experiment Video
Updated: May 10, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure
Thomas E van der Schalk1, Matilda Berkell1,2, An Hottebeekx1,2
1Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Abstract:
Antibiotic combination therapy is often used to broaden the antimicrobial spectrum, limit resistance and improve treatment efficacy. Several antibiotics show collateral effects where resistance to one antibiotic increases susceptibility to another. In intensive care units (ICUs), antibiotic treatments are frequently adjusted based on patient outcomes, without considering collateral effects. This provides a setting to study these effects in Pseudomonas aeruginosa (PA), a highly adaptable, multidrug-resistant (MDR), nosocomial pathogen. We compared longitudinal PA isolates from twenty-five ventilated ICU patients receiving various antibiotics to laboratory strains undergoing in vitro adaptive evolution under four antipseudomonal monotherapies. Prolonged exposure to certain antibiotics produced resistance with collateral effects. In vitro, increasing antibiotic pressure drove distinct mutational trajectories. In patients, the number of antibiotics administered did not correlate with resistance changes to those antibiotics, suggesting that switching may reduce persistence of resistance. Notably, an inverse correlation between resistance to non-administered antibiotics and the number of different antibiotic classes administered, aligns with the principles of collateral susceptibility driven by multi-class exposure. This study provides s real-world evidence that empirical antibiotic mixing in ICU patients leverages evolutionary trade-offs. Consequently, diversifying antibiotic pressure via multi-class exposure may attenuate the fixation and persistence of MDR phenotypes in critical care.
Insights
Antibiotic resistance in intensive care units (ICUs) can be managed by diversifying antibiotic treatments. This approach leverages collateral effects, where resistance to one drug can increase susceptibility to another, reducing multidrug resistance (MDR) in pathogens like Pseudomonas aeruginosa.
Area of Science:
- Microbiology
- Evolutionary Biology
- Clinical Medicine
Background:
- Antibiotic combination therapy is standard in ICUs to combat broad-spectrum pathogens.
- Collateral effects, where resistance to one antibiotic can increase susceptibility to another, are known but often overlooked in clinical practice.
- Pseudomonas aeruginosa (PA) is a multidrug-resistant (MDR), nosocomial pathogen frequently encountered in ICUs.
Purpose of the Study:
- To investigate the impact of antibiotic exposure on resistance and collateral effects in Pseudomonas aeruginosa (PA) within an intensive care unit (ICU) setting.
- To compare in vivo patient data with in vitro adaptive evolution experiments under antibiotic pressure.
- To evaluate whether empirical antibiotic mixing in ICUs influences the evolution of MDR phenotypes.
Main Methods:
- Longitudinal analysis of PA isolates from 25 ventilated ICU patients receiving various antibiotics.
- In vitro adaptive evolution experiments using laboratory PA strains under four different antipseudomonal monotherapies.
- Correlation analysis between antibiotic administration, resistance changes, and collateral susceptibility patterns.
Main Results:
- Prolonged antibiotic exposure in vitro and in vivo led to resistance with collateral effects.
- The number of antibiotics administered did not correlate with resistance to those specific drugs in patients.
- An inverse correlation was observed between resistance to non-administered antibiotics and the diversity of antibiotic classes used, supporting collateral susceptibility principles.
Conclusions:
- Empirical antibiotic mixing in ICUs can exploit evolutionary trade-offs to manage antibiotic resistance.
- Diversifying antibiotic pressure through multi-class exposure may reduce the prevalence and persistence of MDR phenotypes in critical care settings.
- Real-world evidence supports the strategic use of antibiotic combinations to attenuate MDR evolution in ICUs.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Gene Regulation in Microbial Communities: Quorum Sensing

